Graphene oxide, a water-compatible form of graphene, was used in this pioneering study to ensure ultra-purity and compatibility for potential medical applications. This finding comes from the first-ever controlled exposure clinical trial involving human participants, emphasizing the material’s safety under specific conditions. The study was a collaborative effort by researchers from the Universities of Edinburgh and Manchester.